Single-Dose Brachytherapy Effective for Prostate Cancer

MONDAY, April 29, 2019 -- Single-dose high dose-rate (HDR) brachytherapy is safe and effective for low-risk prostate cancer, according to a study presented at ESTRO 38, the annual meeting of the European Society for Radiotherapy and Oncology, held...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news